Scientific Frontline: Extended "At a Glance" Summary: Targeting a Cellular Entrapment Complex to Treat Proteinopathies in Mice
The Core Concept: Broad Institute researchers identified a four-protein intracellular complex—composed of the transmembrane cargo receptors TMED2, TMED7, TMED9, and TMED10—that traps misfolded proteins inside cells and drives pathology in multiple inherited disorders known as proteinopathies. By disrupting this entrapment complex with a small-molecule compound or through genetic deletion of Tmed7 in mice, the team reduced misfolded protein accumulation, reversing disease hallmarks in mucin 1 (MUC1) kidney disease and slowing vision loss in a protein-misfolding model of retinitis pigmentosa.
Key Distinction/Mechanism: In healthy cells, the TMED2/7/9/10 cargo receptor complex manages low-level protein misfolding within the intracellular trafficking and quality-control pathway, but continuous production of mutated proteins in genetic disorders overwhelms this system and causes cargo retention. In mouse genetic models, deleting Tmed7—which stabilizes the entrapment complex—releases trapped mutant proteins for lysosomal degradation while preserving the stability and routine functions of the remaining TMED subunits, although the long-term physiological effects of systemic TMED7 inhibition in humans remain untested. Rather than designing a separate drug for each rare mutation, the researchers frame this strategy as "nodal biology," targeting a shared cellular node implicated across multiple distinct disorders.
Origin/History: In 2019, Broad Institute researcher Anna Greka and colleagues showed that TMED9 becomes overwhelmed and traps misfolded proteins in MUC1 kidney disease, and that disabling TMED9 releases the trapped proteins for lysosomal degradation. Because TMED9 belongs to a nine-member protein family whose subunits assemble in varied combinations, that finding prompted the team to screen all nine TMED proteins in MUC1 kidney disease to determine which subunits form the entrapment complex.







.jpg)
.png)



![Efficient Hydrogen Production via [FeFe]-Hydrogenases Anja Hemschemeier, Thomas Happe, and Zhaoya Yhang (from left) are part of the team of authors.](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjzBYFptX2PrgdoN2xZam0QgqOnyJ3ou4FsdBY4sqZ9WVZPhXrQG2AuowxPoeDZrm_SL9xhmRAlk17QfIZ800Ho4kATVnUPg3gTluKw7gxEWusXO0pOyPK_f7I8KqYmu8qhxTXkiv86ELKaIEuAl1z_3ET75M2qUozTmXegfpUeakGgtZEdLsKwkAq3yHD6/w494-h329/imbchm101926_01_01.jpg)






